Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,866
Sort by:
Global Ovarian Cancer Drugs Market Research and Analysis, 2015-2022
US$ 3,495.00
... most common ovarian cancer type. 1. Global Ovarian Cancer Drugs Market Research And Analysis, By Cancer Type 1.1. Epithelial Ovarian Tumors 1.2. Ovarian Germ Cell Tumors 1.3. Ovarian Stromal Tumors 1.4. Primary Peritoneal Carcinoma 2. Global Ovarian Cancer Drugs Market Research ...
May 2017
Global Cancer Biomarkers Market Analysis & Forecast Report 2017
US$ 2,600.00
The Global Cancer Biomarkers Market Analysis & Forecast Report 2017 is a professional and in-depth study on the current state of the Cancer Biomarkers Market. The report analysis the global market of Cancer Biomarkers by main manufactures and geographic regions. The report includes Cancer Biomarkers definitions, classifications, applications and ...
May 2017
95 pages
Global Endometrial Cancer Therapeutics Market By Therapy (Chemotherapy, Hormone Therapy, Radiation Therapy, Surgery), By Enduser (Research Institutes, Hospitals & Clinics), & Pipeline Analysis, Outlook to 2023
US$ 2,500.00
... I or II endometrial cancer. Radiation Therapy is also recommended in patients who have undergone the surgery to avoid the relapse of endometrial cancer. According to the RNCOS report entitled “Global Endometrial Cancer Therapeutics Market By Therapy (Chemotherapy, Hormone Therapy, Radiation Therapy, Surgery), By Enduser (Research Institutes, Hospitals & Clinics), & Pipeline Analysis, Outlook to 2023”, the Endometrial Cancer therapeutics market is poised ...
May 2017
100 pages
Ovarian Cancer [2017]
US$ 8,145.00
... an alternative to chemotherapy in the treatment of relapsed BRCA-mutated high-grade ovarian cancer? How will recently approved Zejula compete with the existing ... term outlook for Avastin in ovarian cancer? How do KOLs view the combination of cediranib with Lynparza as a treatment for recurrent ovarian cancer? Quotes “Some of these ...
April 2017
Global Non-Specific Cancer Immunotherapy Drug Industry Market Research 2017
US$ 2,600.00
... driving the global Non-Specific Cancer Immunotherapy Drug industry? 8. What are the key market trends impacting the growth of the Non-Specific Cancer Immunotherapy Drug market? 9. What are the Non-Specific Cancer Immunotherapy Drug market challenges to market growth? 10. What are the Non-Specific Cancer Immunotherapy Drug market opportunities and threats faced by the vendors in the global Non-Specific Cancer Immunotherapy Drug market ...
April 2017
156 pages
Global Specific Cancer Immunotherapy Drugs Industry Market Research 2017
US$ 2,600.00
... driving the global Specific Cancer Immunotherapy Drugs industry? 8. What are the key market trends impacting the growth of the Specific Cancer Immunotherapy Drugs market? 9. What are the Specific Cancer Immunotherapy Drugs market challenges to market growth? 10. What are the Specific Cancer Immunotherapy Drugs market opportunities and threats faced by the vendors in the global Specific Cancer Immunotherapy Drugs market ...
April 2017
145 pages
North America Prostate Cancer Diagnostics Market by Manufacturers, Countries, Type and Application, Forecast to 2022
US$ 4,480.00
... exam, biopsy and others to diagnostic whether patients with breast cancer. SCOPE OF THE REPORT: This report focuses on the Prostate Cancer Diagnostics in North America market, especially in United ... into < 55 55-75 > 75 There are 15 Chapters to deeply display the North America Prostate Cancer Diagnostics market. Chapter 1, to describe Prostate Cancer Diagnostics Introduction, product type and application, market overview, market ...
April 2017
119 pages
Global Breast Cancer Predictive Genetic Testing Market Outlook 2022
US$ 2,000.00
... Breast Cancer Predictive Genetic Testing Market Outlook 2022” Report Highlights: Hereditary Breast Cancer Genes Conceptual of Breast Cancer Susceptibility Predictive Cancer Testing Essentials Economical, Ethical & Social Aspects Global Prevalence of Breast Cancer Market & Cost Analysis of Predictive Testing ...
April 2017
140 pages
Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022
US$ 2,400.00
... cancer vaccine, 44 Cancer monoclonal antibodies, 3 cancer cell therapies and 61 cancer Immunomodulators are commercially available in the market. Pharmaceutical companies are actively engaged in research and development of cancer immunotherapies ...
April 2017
280 pages
Cancer Diagnostics 2021: Supplier Shares and Strategies, Country Segment Forecasts, Tehnology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 31,275.00
... Current and Emerging Cancer Diagnostic Test Oncogenes Biochemical Markers Growth Factors Colony Stimulating Factors Hormones Immunohistochemical Stains Lymphokines Supplier Shares, Sales and Volume Forecasts Sales and market shares of major cancer diagnostic product suppliers by individual test and country ...
March 2017
1200 pages
2017 Spain Hospital Hematology and Flow Cytometry Markets
US$ 3,465.00
... a comprehensive analysis of the Spanish hospital hematology and flow cytometry markets, including: Major issues pertaining to the Spanish hematology and flow cytometry practice ... major hematology and flow cytometry tests performed in Spanish hospitals. Annual placements and installed base estimates for major automated and semiautomated hematology ...
March 2017
236 pages
2017 Germany Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Instrument and Reagent Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies
US$ 5,490.00
... explores future marketing and technological trends in the Germany; provides estimates of the test volume, instrument placements ... ten years.Blood Typing and Grouping TestsABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, ...
March 2017
426 pages
2017 Japan Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Instrument and Reagent Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies
US$ 6,930.00
... report explores future marketing and technological trends in the Japan; provides estimates of the test volume, instrument placements ... ten years.Blood Typing and Grouping TestsABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, ...
March 2017
426 pages
2017 Europe Coagulation Reagent and Instrument Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK
US$ 17,730.00
... and consumable suppliers during the next five years. Coagulation Tests Activated Clotting Time (ACT) (1), Activated Protein C Resistance, ... and operating characteristics. Alternative market penetrationstrategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains ...
March 2017
500 pages
2017 Australia Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Austria Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Belgium Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Bulgaria Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Canada Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Cyprus Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Czech Republic Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales for major cancer diagnostics tests ...
March 2017
535 pages
2017 Denmark Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Estonia Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Finland Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Greece Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Hungary Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Iceland Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Ireland Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Latvia Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Lithuania Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Malta Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Netherlands Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Norway Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages